Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals

Serum hepatitis B virus (HBV)-DNA > 2,000 IU/mL is associated with higher risk of disease progression. However, without hepatocellular carcinoma (HCC) or cirrhosis, nucleos(t)ide analogs (NUCs) are recommended only for patients with elevated serum HBV-DNA and alanine aminotransferase ≥2 × upper n...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hye Won, Kim, Seung Up, Park, Jun Yong, Baatarkhuu, Oidov, Kim, Do Young, Ahn, Sang Hoon, Han, Kwang-Hyub, Kim, Beom Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613858/
https://www.ncbi.nlm.nih.gov/pubmed/31107725
http://dx.doi.org/10.14309/ctg.0000000000000036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613858/
https://www.ncbi.nlm.nih.gov/pubmed/31107725
http://dx.doi.org/10.14309/ctg.0000000000000036

Ejemplares similares